Compare LPA & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LPA | CBUS |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Agricultural Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.2M | 69.9M |
| IPO Year | N/A | 2017 |
| Metric | LPA | CBUS |
|---|---|---|
| Price | $2.60 | $1.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 29.3K | ★ 188.7K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $47,536,343.00 | $3,794,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $109.96 |
| P/E Ratio | $12.44 | ★ N/A |
| Revenue Growth | ★ 7.28 | N/A |
| 52 Week Low | $2.55 | $1.09 |
| 52 Week High | $11.16 | $3.40 |
| Indicator | LPA | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 35.71 | 64.89 |
| Support Level | $2.65 | $1.59 |
| Resistance Level | $2.94 | $1.80 |
| Average True Range (ATR) | 0.17 | 0.14 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 2.38 | 89.70 |
Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has three operating segments, based on geographic regions, consisting of Colombia, Peru, and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.